Ramakrishnan, V. G., Miller, K. C., Macon, E. P., Kimlinger, T. K., Haug, J., Kumar, S., . . . Kumar, S. K. (2019). Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma. Haematologica.
Chicago ZitierstilRamakrishnan, Vijay G., Kevin C. Miller, Elaine P. Macon, Teresa K. Kimlinger, Jessica Haug, Sanjay Kumar, Wilson I. Gonsalves, S. Vincent Rajkumar, und Shaji K. Kumar. "Histone Deacetylase Inhibition in Combination With MEK or BCL-2 Inhibition in Multiple Myeloma." Haematologica 2019.
MLA ZitierstilRamakrishnan, Vijay G., et al. "Histone Deacetylase Inhibition in Combination With MEK or BCL-2 Inhibition in Multiple Myeloma." Haematologica 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.